[Recent progress in understanding molecular pathogenesis of Fanconi anemia].
Yamashita
Takayuki
T
Oda
Tsukasa
T
Sekimoto
Takayuki
T
D051017:Apoptosis Regulatory Proteins; D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein / Q000235:genetics; D016922:Cellular Senescence; D004247:DNA / Q000096:biosynthesis; D004249:DNA Damage; D004259:DNA-Directed DNA Polymerase / Q000502:physiology; D005199:Fanconi Anemia / Q000235:genetics*; D052217:Fanconi Anemia Complementation Group A Protein / Q000235:genetics; D052218:Fanconi Anemia Complementation Group C Protein / Q000235:genetics; D051856:Fanconi Anemia Complementation Group Proteins / Q000235:genetics; D042822:Genomic Instability; D006412:Hematopoietic Stem Cells; D006801:Humans; D009154:Mutation; D018384:Oxidative Stress
D051017:Apoptosis Regulatory Proteins; C118024:BLID protein, human; D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; C498471:FANCA protein, human; C497651:FANCC protein, human; C519921:FANCI protein, human; D052217:Fanconi Anemia Complementation Group A Protein; D052218:Fanconi Anemia Complementation Group C Protein; D051856:Fanconi Anemia Complementation Group Proteins; D004247:DNA; D004259:DNA-Directed DNA Polymerase